FDA Approves AstraZeneca's (AZN) Iressa for First-line Treatment of Patients with Type of Metastatic Lung Cancer (QGEN)
Tweet Send to a Friend
(Updated - July 13, 2015 1:34 PM EDT)The U.S. Food and Drug Administration today approved Iressa (gefitinib) for the first-line ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
